Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
17
-
Total 13F shares, excl. options
-
1,507,252
-
Shares change
-
-31,681
-
Total reported value, excl. options
-
$1,463,000
-
Value change
-
-$183,930
-
Number of buys
-
9
-
Number of sells
-
9
-
Price
-
$0.9710
Institutional Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q3 2019
As of 30 Sep 2019 IGC Pharma, Inc. - COM NEW (IGC) had 17 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,507,252 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, Carroll Financial Associates, Inc., DEARBORN PARTNERS LLC, NORTHERN TRUST CORP, GOLDMAN SACHS GROUP INC, Creative Planning, SUSQUEHANNA INTERNATIONAL GROUP, LLP, BANK OF MONTREAL /CAN/, and CITADEL ADVISORS LLC.
This table shows 17 institutional shareholders of the security as of 30 Sep 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.